Van onze partners – Pagina 12
-
Partnerbijdragen
Intensified bioprocesses require efficient media and clever buffers
Cell culture media and buffers are an important factor in bioprocessing. Where media determine cell growth and upstream productivity, buffer concepts determine downstream footprint and efficiency. How can optimal formulation and formatting of these essential materials help to produce better and cheaper medicines? Process intensification is a major theme in ...
-
Partnerbijdragen
Challenges in single-use and how to solve them
Single-use technology has now been established as the major technology used within global bioproduction facilities. While several challenges still remain, they are becoming less of an issue as the industry moves forward. Graeme Proctor, Product Manager Single Use Technologies at Parker Bioscience Filtration, discusses some of these. Single-use processing has ...
-
Partnerbijdragen
The challenges of continuous bioproduction
This article was written in close collaboration with our commercial partners GE Healthcare Life Sciences, Sartorius Stedim Biotech, Merck, and PALL Life Sciences.
-
PartnerbijdragenTim Jaarsma (IMI) on automation in bioprocessing
“We are looking at production processes in cell and gene therapy that have so far mainly been done manually,” says Tim Jaarsma of IMI.
-
PartnerbijdragenJohn Rook (Lonza) on the use of Single Use in large scale manufacturing: The Hybrid Approach
John Rook works for Lonza as a process expert assisting the start-up of the new large scale manufacturing site in Visp, Switzerland.
-
PartnerbijdragenRuud Verstegen (Byondis) on single-use technology in biopharma manufacturing
Ruud Verstegen shares his perspective on single-use technology as a process engineer at Byondis.